Rarefaction curves of quality reads per sample at (A) phylum and (B) genus level operational taxonomic units (OTUs), in patient and control samples. by Duangnapa Roongpiboonsopit (12829198)

Subjects:

Screening HBV RNaseH inhibitors in HepDES19 cell for effects on capsids and core protein. by Daniel P. Bradley (10306893)

The top 10 putative metabolites with the largest negative fold change between normal and thin cows. by Bhuripit Saraphol (20855573)

Subjects:

The top 10 putative metabolites with the largest positive fold change between normal and thin cows. by Bhuripit Saraphol (20855573)

Subjects:

The principal component analysis (PCA) plot utilized in the quality assurance process. by Bhuripit Saraphol (20855573)

Subjects:

Diversity of the fecal microbiome in normal and thin cows according to 16S rRNA gene sequencing data. by Bhuripit Saraphol (20855573)

Subjects:

The numbers of normal and thin cows from each farm. by Bhuripit Saraphol (20855573)

Subjects:

Multivariate and clustering analysis of metabolomic data. by Bhuripit Saraphol (20855573)

Subjects:

Results of the pathway analysis performed using the STITCH bioinformatics tool. by Bhuripit Saraphol (20855573)

Subjects:

Raw metabolomic data. by Bhuripit Saraphol (20855573)

Subjects:

Stacked bar plots illustrating the relative abundance distribution of fecal microbial communities in thin and normal cows. by Bhuripit Saraphol (20855573)

Subjects:

Schematic diagram of the experimental workflow. by Bhuripit Saraphol (20855573)

Subjects:

The effect of HA digestion and HA replenishment alone or with CS on barrier function measured by TEER. by Charlotte J. van Ginkel (20790466)

“…PS decreased TEER. (C) Different treatments (treatment groups n = 8)with HA and/or CS did not affect TEER recovery after PS treatment, full recovery was seen in all groups after 24 hours. …”

Effects of compound 4f on neuroinflammation in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Subjects:

Top 20 IPA pathways of 2405 genes downregulated following KA treatment with a <i>P</i>-value of < 0.05. by Naoto Arimura (416442)

Subjects:

All data in the manuscript and supporting information. by Naoto Arimura (416442)

Subjects:

The effects of cannabinoid receptor antagonists against neuroprotective effects of compound 4f in KA-treated mice. by Naoto Arimura (416442)

Subjects:

Representative image data in Fig 5. by Naoto Arimura (416442)

Subjects:

Pharmacokinetics and pharmacodynamics of compound 4f in mice. by Naoto Arimura (416442)

Subjects:

Effects of compound 4f on cognitive function in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Subjects: